ABK Biomedical Raises $35M Series D Led by J.P. Morgan Life Sciences Private Capital

Deal Summary

ABK Biomedical, a Halifax-based medical device company, raised $35M in a Series D financing round led by J.P. Morgan Life Sciences Private Capital, with participation from F-Prime, Santé Ventures, and Eight Roads Ventures. Proceeds will support development and commercialization of the company's imageable embolic medical devices.